MedPath

A Post-marketing Study to Evaluate a Novel Surgical Monitoring Technique Using the EARP Nerve Cuff in TLIF Surgery.

Not Applicable
Recruiting
Conditions
Transforaminal Lumbar Interbody Fusion Surgery
Registration Number
NCT06204900
Lead Sponsor
Retropsoas Technologies, LLC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Inclusion Criteria:<br><br>• Undergoing a single-level or two-level TLIF between L2-S1<br><br>Exclusion Criteria:<br><br> - Requiring lumbar interbody fusion of greater than two levels<br><br> - Requiring TLIF surgery only at the L5-S1 level<br><br> - Acute lumbar spine trauma requiring immediate intervention<br><br> - Previous cervical stenosis surgery or lumbar fusion surgery at the level of interest<br><br> - BMI > 40 kg/m2<br><br> - Currently smoking<br><br> - Grade of weakness of < 4/5 in a lower extremity muscle<br><br> - Peripheral vascular disease or peripheral neuropathy<br><br> - Allergy or contraindication to propofol<br><br> - Lower extremity amputation<br><br> - Significant lower extremity edema noted on clinical exam<br><br> - History of drug or alcohol abuse<br><br> - High degrees of somatization on clinical or psychological evaluation<br><br> - Presence of a personality disorder or major psychiatric illness<br><br> - Greater than 12 months of disability or not working secondary to medical condition<br><br> - HbA1C >7.0% during pre-admission testing<br><br> - Active systemic bacterial or fungal infection or infection at operative site noted<br> during pre-operative physical exam<br><br> - Current treatment with chemotherapy, radiation, immunosuppression or chronic steroid<br> therapy<br><br> - Pregnant, or plans on becoming pregnant in the near future<br><br> - History of allergy to titanium, platinum, PEEK or silico

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of patients that experience an Adverse Device Effect (ADE);Ability of EARP System to alert the surgeon to nerve irritation during surgery compared to standard IONM monitoring techniques
Secondary Outcome Measures
NameTimeMethod
Evaluate the specificity and sensitivity of alerts to neurological deficits.;Assess monitorability of muscles/nerves;Assess the change from baseline to end of surgery for each muscle and modality
© Copyright 2025. All Rights Reserved by MedPath